MidregiOn Proatrial Natriuretic Peptide to Guide SEconadry Stroke Prevention

Condition:   Stroke, Ischemic Interventions:   Drug: Rivaroxaban;   Drug: Dabigatran;   Drug: Apixaban;   Drug: Edoxaban;   Drug: Aspirin;   Drug: Clopidogrel Sponsor:   University of Zurich Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials